These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7694421)

  • 21. Expression of involucrin by ocular surface epithelia of patients with benign and malignant disorders.
    Saika S; Minamide A; Tanaka T; Miyamoto T; Okada Y; Kawashima Y; Ohnishi Y; Ooshima A; Kao WW
    Curr Eye Res; 2000 Nov; 21(5):877-85. PubMed ID: 11262609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of TPA and cytokeratins in gastrointestinal carcinomas as revealed by immunohistochemistry.
    Beham A; Weybora W; Lackinger E; Denk H; Björklund V; Björklund B
    Virchows Arch A Pathol Anat Histopathol; 1986; 409(5):641-55. PubMed ID: 2428164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokeratins 7 and 14 in special types of invasive breast carcinomas.
    Toth T
    Med Pregl; 1999; 52(6-8):227-32. PubMed ID: 10518377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involucrin in intraepithelial and invasive squamous cell carcinomas of the cervix: an immunohistochemical study.
    Sassoon AF; Said JW; Nash G; Shintaku IP; Banks-Schlegel S
    Hum Pathol; 1985 May; 16(5):467-70. PubMed ID: 3886522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of cytokeratin 10, 13, and involucrin as prognostic factors in low stage squamous cell carcinoma of the uterine cervix.
    van Bommel PF; Kenemans P; Helmerhorst TJ; Gallee MP; Ivanyi D
    Cancer; 1994 Oct; 74(8):2314-20. PubMed ID: 7522949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunocytochemical detection of involucrin in precancerous and cancerous non-pigmented conjunctival tumors].
    Holbach L; Hofmann C; Völcker HE; Naumann GO
    Klin Monbl Augenheilkd; 1986 Aug; 189(2):128-32. PubMed ID: 3531699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MIB-1 and involucrin expression in laryngeal squamous carcinoma: the relationship to host and tumour factors and survival.
    Roland NJ; Rowley H; Scraggs M; Johnson P; Jones AS
    Clin Otolaryngol Allied Sci; 1996 Oct; 21(5):429-38. PubMed ID: 8932948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome.
    van de Rijn M; Perou CM; Tibshirani R; Haas P; Kallioniemi O; Kononen J; Torhorst J; Sauter G; Zuber M; Köchli OR; Mross F; Dieterich H; Seitz R; Ross D; Botstein D; Brown P
    Am J Pathol; 2002 Dec; 161(6):1991-6. PubMed ID: 12466114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Squamoid features and expression of involucrin in primary breast carcinoma associated with high histological grade, tumour cell necrosis and recurrence sites.
    Tsuda H; Sakamaki C; Fukutomi T; Hirohashi S
    Br J Cancer; 1997; 75(10):1519-24. PubMed ID: 9166948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of polypeptide expression in benign and malignant human breast lesions: down-regulation of cytokeratins.
    Franzén B; Linder S; Alaiya AA; Eriksson E; Uruy K; Hirano T; Okuzawa K; Auer G
    Br J Cancer; 1996 Nov; 74(10):1632-8. PubMed ID: 8932346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical localization of keratins and involucrin in solar keratosis and Bowen's disease.
    Ichikawa E; Watanabe S; Otsuka F
    Am J Dermatopathol; 1995 Apr; 17(2):151-7. PubMed ID: 8600780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The distribution of cytokeratin antigens in the kidney and in renal tumours.
    Fleming S; Symes CE
    Histopathology; 1987 Feb; 11(2):157-70. PubMed ID: 2437002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoxia and differentiation in squamous cell carcinomas of the uterine cervix: pimonidazole and involucrin.
    Azuma Y; Chou SC; Lininger RA; Murphy BJ; Varia MA; Raleigh JA
    Clin Cancer Res; 2003 Oct; 9(13):4944-52. PubMed ID: 14581369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokeratin expression in human thymus: immunohistochemical mapping.
    Shezen E; Okon E; Ben-Hur H; Abramsky O
    Cell Tissue Res; 1995 Jan; 279(1):221-31. PubMed ID: 7534649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of cytokeratin messenger RNA versus protein in the normal mammary gland and in breast cancer.
    Su L; Morgan PR; Lane EB
    Hum Pathol; 1996 Aug; 27(8):800-6. PubMed ID: 8760013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of keratin and involucrin in keratoacanthoma: an immunohistochemical aid to diagnosis.
    Ichikawa E; Ohnishi T; Watanabe S
    J Dermatol Sci; 2004 Apr; 34(2):115-7. PubMed ID: 15033195
    [No Abstract]   [Full Text] [Related]  

  • 37. Basal cell-specific and hyperproliferation-related keratins in human breast cancer.
    Wetzels RH; Kuijpers HJ; Lane EB; Leigh IM; Troyanovsky SM; Holland R; van Haelst UJ; Ramaekers FC
    Am J Pathol; 1991 Mar; 138(3):751-63. PubMed ID: 1705754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical markers of human sebaceous gland differentiation.
    Latham JA; Redfern CP; Thody AJ; De Kretser TA
    J Histochem Cytochem; 1989 May; 37(5):729-34. PubMed ID: 2467930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involucrin, a marker of squamous and urothelial differentiation. An immunohistochemical study on its distribution in normal and neoplastic tissues.
    Walts AE; Said JW; Siegel MB; Banks-Schlegel S
    J Pathol; 1985 Apr; 145(4):329-40. PubMed ID: 3889247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokeratins in cervical dysplasia and neoplasia: a comparative study of immunohistochemical staining using monoclonal antibodies NCL-5D3, CAM 5.2, and PKK1.
    Angus B; Kiberu S; Purvis J; Wilkinson L; Horne CH
    J Pathol; 1988 May; 155(1):71-5. PubMed ID: 2454306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.